1. Home
  2. BYSI vs RMTI Comparison

BYSI vs RMTI Comparison

Compare BYSI & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

HOLD

Current Price

$0.60

Market Cap

35.8M

Sector

Health Care

ML Signal

HOLD

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

HOLD

Current Price

$8.05

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYSI
RMTI
Founded
2010
1994
Country
United States
United States
Employees
N/A
300
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.8M
29.9M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
BYSI
RMTI
Price
$0.60
$8.05
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
1.9M
27.0K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$69,258,000.00
Revenue This Year
N/A
$8.64
Revenue Next Year
N/A
$8.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.55
52 Week High
$2.44
$8.50

Technical Indicators

Market Signals
Indicator
BYSI
RMTI
Relative Strength Index (RSI) 32.71 62.47
Support Level $0.57 $0.79
Resistance Level $1.25 N/A
Average True Range (ATR) 0.06 0.42
MACD 0.01 -0.09
Stochastic Oscillator 27.16 63.68

Price Performance

Historical Comparison
BYSI
RMTI

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

Share on Social Networks: